- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6750
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Tuning the performance of CAR T cell immunotherapies ; volume:19 ; number:1 ; day:29 ; month:11 ; year:2019 ; pages:1-7 ; date:12.2019
BMC biotechnology ; 19, Heft 1 (29.11.2019), 1-7, 12.2019
- Creator
-
Richardson, Noah H.
Luttrell, Jordan B.
Bryant, Jonathan S.
Chamberlain, Damian
Khawaja, Saleem
Neeli, Indira
Radic, Marko
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12896-019-0576-9
- URN
-
urn:nbn:de:101:1-2020032423424623976175
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Richardson, Noah H.
- Luttrell, Jordan B.
- Bryant, Jonathan S.
- Chamberlain, Damian
- Khawaja, Saleem
- Neeli, Indira
- Radic, Marko
- SpringerLink (Online service)
Other Objects (12)
Fine-tuning anti-tumor immunotherapies via stochastic simulations
Bispecific antibodies and CAR-T cells: dueling immunotherapies for large B-cell lymphomas
CAR-Immunotherapies for the treatment of metastatic rhabdomyosarcomas
Prospects for Development of Induced Pluripotent Stem Cell-Derived CAR-Targeted Immunotherapies
Dynamic fine-tuning of CAR-T cell therapy
Dynamic fine-tuning of CAR-T cell therapy
Safety profile of chimeric antigen receptor T-cell immunotherapies (CAR-T) in clinical practice
A deep insight into CRISPR/Cas9 application in CAR-T cell-based tumor immunotherapies
Neurological complications associated with cancer immunotherapies - allogeneic stem cell transplantation, immune checkpoint inhibition, and CAR T cell therapy
Synthetic Cell-Based Immunotherapies for Neurologic Diseases
Molecular imaging biomarkers for cell-based immunotherapies
Dual-targeted CAR T-cell immunotherapies for hematological malignancies: latest updates from the 2023 ASH annual meeting
Fine-tuning anti-tumor immunotherapies via stochastic simulations
Bispecific antibodies and CAR-T cells: dueling immunotherapies for large B-cell lymphomas
CAR-Immunotherapies for the treatment of metastatic rhabdomyosarcomas
Prospects for Development of Induced Pluripotent Stem Cell-Derived CAR-Targeted Immunotherapies
Dynamic fine-tuning of CAR-T cell therapy
Dynamic fine-tuning of CAR-T cell therapy
Safety profile of chimeric antigen receptor T-cell immunotherapies (CAR-T) in clinical practice
A deep insight into CRISPR/Cas9 application in CAR-T cell-based tumor immunotherapies
Neurological complications associated with cancer immunotherapies - allogeneic stem cell transplantation, immune checkpoint inhibition, and CAR T cell therapy
Synthetic Cell-Based Immunotherapies for Neurologic Diseases
Molecular imaging biomarkers for cell-based immunotherapies
Dual-targeted CAR T-cell immunotherapies for hematological malignancies: latest updates from the 2023 ASH annual meeting
Fine-tuning anti-tumor immunotherapies via stochastic simulations
Bispecific antibodies and CAR-T cells: dueling immunotherapies for large B-cell lymphomas
CAR-Immunotherapies for the treatment of metastatic rhabdomyosarcomas
Prospects for Development of Induced Pluripotent Stem Cell-Derived CAR-Targeted Immunotherapies
Dynamic fine-tuning of CAR-T cell therapy
Dynamic fine-tuning of CAR-T cell therapy
Safety profile of chimeric antigen receptor T-cell immunotherapies (CAR-T) in clinical practice
A deep insight into CRISPR/Cas9 application in CAR-T cell-based tumor immunotherapies
Neurological complications associated with cancer immunotherapies - allogeneic stem cell transplantation, immune checkpoint inhibition, and CAR T cell therapy
Synthetic Cell-Based Immunotherapies for Neurologic Diseases
Molecular imaging biomarkers for cell-based immunotherapies